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Abstract
Despite many years of research, outcome after cardiac arrest is dismal. Since 2005, the European
Resuscitation Council recommends in its guidelines the use of mild therapeutic hypothermia (32-
34°) for 12 to 24 hours in patients successfully resuscitated from cardiac arrest. The benefit of
resuscitative mild hypothermia (induced after resuscitation) is well established, while the benefit of
preservative mild to moderate hypothermia (induced during cardiac arrest) needs further
investigation before recommending it for clinical routine. Animal data and limited human data
suggest that early and fast cooling might be essential for the beneficial effect of resuscitative mild
hypothermia. Out-of-hospital cooling has been shown to be feasible and safe by means of
intravenous infusion with cold fluids or non-invasively with cooling pads. A combination of these
cooling methods might further improve cooling efficacy. If out-of-hospital cooling will further
improve functional outcome as compared with in-hospital cooling needs to be determined in a
prospective, randomised, sufficiently powered clinical trial.
Background
Sudden cardiac arrest remains a major unresolved public
health problem. In Europe and the USA, approximately
425.000 people suffer of sudden cardiac death with very
poor survival, usually less than 10% [1,2]. After cardiac
arrest and brain ischemia, reperfusion initiates multiple
independent chemical cascades and fatal pathways, result-
ing in neuronal death due to necrosis and apoptosis [3].
Because of the multi-factorial pathogenesis of post-arrest
neuronal death, a multifaceted treatment strategy is
required to achieve survival without brain damage. Hypo-
thermia, a re-discovered promising treatment strategy,
exerts its beneficial effects on brain ischemia by various
mechanisms, and perfectly fulfils the requirements of a
multifaceted treatment strategy [4].
In therapeutic hypothermia, different degrees of cooling
can be differentiated, though definition of these tempera-
ture levels may differ slightly between authors: mild (34
to 32°C), moderate (31 to 28°C), deep (27 to 11°C), pro-
found (10 to 6°C), and ultra-profound (5 to 0°C) hypo-
thermia. Protective hypothermia, induced before cardiac
arrest, has to be differentiated from preservative hypother-
mia, induced during cardiac arrest treatment, and from
resuscitative hypothermia, induced after successful resus-
citation. Protective hypothermia is used in cardiac surgery
and neurosurgery, but is clinically unrealistic in sudden
cardiac death. This review will focus on a) preservative
mild hypothermia during cardiac arrest treatment and b)
resuscitative mild hypothermia after successful resuscita-
tion in respect to its clinical application in the out-of-hos-
pital setting.
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Preservative hypothermia
Preservative hypothermia can further be differentiated
into the induction of hypothermia during ischemia
(before initiation of resuscitation - or before reperfusion)
and the induction of hypothermia during resuscitation.
Induction of hypothermia during ischemia, before 
resuscitation
Research in myocytes showed that injury to cells not only
occurs during ischemia itself, but mainly with reperfusion
by initiating several cascades leading to cell death [5-7].
Besides other effects, intra-ischemic hypothermia attenu-
ates the inflammatory response [8], oxidative DNA dam-
age and DNA damage-triggered pro-death signalling after
resuscitation [9]. In various animal studies using vessel
occlusion or cardiac arrest models, the induction of hypo-
thermia already during cardiac arrest (before the start of
resuscitation) improved outcome as compared with hypo-
thermia induced after successful resuscitation [10-17].
Importantly, a delay of resuscitation efforts to allow estab-
lishment of hypothermia before reperfusion, did not
affect the beneficial effect of hypothermia on cardiac func-
tion and survival [18,19].
The induction of hypothermia during ischemia, before
resuscitation, is an intriguing concept, but reserved for
experimental animal studies. Before bringing this concept
into clinical reality, many questions need to be answered:
how long can resuscitation be delayed for the purpose of
inducing hypothermia? Which level of hypothermia has
to be induced? How long to maintain a certain level of
hypothermia before re-warming?
Induction of hypothermia during resuscitation
Induction of hypothermia during resuscitation is a more
realistic clinical scenario, because resuscitation does not
have to be delayed for induction of hypothermia. In a
swine cardiac arrest model, induction of mild hypother-
mia with beginning of resuscitation improved resuscita-
bilty, but not short term neurologic outcome [20]; mild
hypothermia was induced with an i.v. infusion of 30 ml/
kg 4° cold saline. In another swine study, surface cooling
to 34°C during the first 30 minutes of prolonged resusci-
tation increased rate of restoration of spontaneous circu-
lation [21]. In a dog cardiac arrest model, induction of
mild hypothermia with veno-venous blood shunt cooling
during prolonged cardiac arrest improved neurologic out-
come as compared to normothermia [22], but hypother-
mia had to be induced very early during resuscitation,
otherwise its beneficial effect was diminished [23].
Only three explorative human studies investigated the fea-
sibility of cooling during resuscitation in the out-of-hos-
pital setting [24-26]. In the study by Bruel et al [24],
hypothermia was induced in 33 patients by i.v. infusion
of 2 l of 4°C normal saline 0.9% over 30 minutes with
pressure bags during advanced life support prior to arrival
at the hospital; the oesophageal temperature decreased
significantly by -2.1°C ± 0.29°C after cooling to a median
temperature of 33.3°C (IQR 32.3-34.3); twenty (61%) of
the patients were successfully resuscitated, in whom mild
hypothermia (<34°C) was achieved 16 min (IQR 12-25)
after ROSC; the time delay to start cooling, and how many
patients have achieved ROSC before the total volume was
infused, were not reported; one patient developed pulmo-
nary oedema; 3 (9%) patients survived with good neuro-
logic outcome. The other two studies were performed by
Kämäräinen et al [25,26]. Since the second study [26]
includes patients of the first study [25], only the second
study will be discussed here: hypothermia was induced in
17 patients by i.v. infusion of 4°C Ringers acetate with a
rate of 50 ml/min during resuscitation, and a rate of 100
ml/min after resuscitation until a nasopharyngeal temper-
ature of 33°C was achieved. Cooling was started at 12 min
after start of CPR at initial nasopharyngeal temperature of
35.17 ± 0.57°C. Temperature on hospital admission was
33.83 ± 0.77°C (-1.34°C, p < 0.001). Mean infused vol-
ume of cold fluid was 1571 ± 517 ml. Thirteen (76%) of
the patients were successfully resuscitated, and 1 (6%)
patient survived with good neurologic outcome.
These preliminary studies [24-26] proved the feasibility of
inducing mild hypothermia during resuscitation with i.v.
infusion of 4° cold fluids in cardiac arrest patients. But
there is no human outcome data today to support the use
of volume loading during resuscitation in daily clinical
practice. The influence of volume load during resuscita-
tion on resuscitabilty has to be evaluated first in large ani-
mal outcome studies. It remains to be determined
whether the potential beneficial effect of hypothermia on
neurologic function is offset by a deleterious effect on sur-
vival. Temperature regulation with infusion of cold fluids
during low-flow has to be considered: in the first study by
Kämäräinen et al [25], the lowest mean temperature was
31.7°C, which is lower as the recommended target range
of 32-34°C. Volume load during resuscitation might
increase right arterial pressure, which might result in
reduced vital organ perfusion [27], and thereby worse out-
come.
Resuscitative hypothermia
Already in the 1960s, Peter Safar recommended the use of
resuscitative mild hypothermia after successful resuscita-
tion from cardiac arrest in his ABC of post cardiac arrest
care [28]. Resuscitative hypothermia research was then
given up for 25 years, because experimental and clinical
trials had been complicated by the injurious systemic
effects of total body cooling. In 2002, results of two pro-
spective randomised clinical trials showed that mild
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fibrillation improved survival and neurologic outcome in
cardiac arrest survivors compared to patients treated with
normothermia [29,30]. In 2005, the guidelines of the
European Resuscitation Council recommended: "Uncon-
scious adult patients with spontaneous circulation after out-of-
hospital ventricular fibrillation cardiac arrest should be cooled
to 32-34°C. Cooling should be started as soon as possible and
continued for at least 12-24 h. Induced hypothermia might also
benefit unconscious adult patients with spontaneous circulation
after out-of-hospital cardiac arrest from a non-shockable
rhythm, or cardiac arrest in hospital" [31].
The deleterious cascades of neuronal death start already
during cardiac arrest, but are boosted with start of reper-
fusion [3]. In view of the pathophysiology on how neu-
rons die, it would be logical to start with mild
hypothermia treatment as soon as possible after resuscita-
tion. In fact, animal studies show consistently that a delay
in cooling negates the beneficial effect of mild hypother-
mia after cardiac arrest [32-35]. Based on these animal
studies and on the pathophysiologic mechanisms of cell
death, the 2005 guidelines of the European Resuscitation
Council recommended: "... Cooling should be started as soon
as possible ..." [31]. Concerning human data, the evidence
for the importance of timing of cooling is very limited.
One retrospective human study in 49 patients showed in
multivariate analyses that any hour delay till coldest tem-
perature or target temperature tended to worsen the like-
lihood for a favourable outcome by approximately 27%
or 31%, respectively [36]; this study did not prove the
importance of early cooling, but rather indicates the
importance of fast cooling once initiated: time to start
cooling was delayed, and did not differ between the
patients with good outcome and poor outcome (both
groups median of 150 minutes), but there was a statisti-
cally significant difference in time to coldest temperature
of median 443 minutes in patients with good outcome as
compared with median 555 minutes in patients with poor
outcome. However, in an observational study in 975
patients after cardiac arrest, time to initiation of therapeu-
tic hypothermia and time to reach the goal temperature
had no significant association with outcome [37].
If the recommendations of the European Resuscitation
Council [31] were followed, treatment with mild hypo-
thermia might have to be started already in the out-of-
hospital setting. The cooling methods for induction of
mild hypothermia in the out-of-hospital setting need to
be easy to use in order not to distract paramedics and phy-
sicians from other aspects of post-resuscitation care
(timely transport to the hospital, ventilation, blood pres-
sure control, and others); and at the same time, cooling
methods should effectively decrease temperature. For in-
hospital cooling, rapid intravenous infusion of cold fluids
after cardiac arrest is well tolerated and feasible for induc-
tion of mild hypothermia [38-42]. In addition to infusion
of cold fluids, various non-invasive [29,43-47] and inva-
sive cooling methods are available [43,44,48-50], but
these cooling devices are heavy, bulky, and need energy
supply during use, which makes them unsuitable for use
in the out-of-hospital setting.
Easy to use non-invasive cooling methods for induction of
mild hypothermia in the out-of-hospital setting include
simple ice-packs [30,51,52] or cooling pads, which adhere
to the patients skin [53]. Ice bags have only limited cool-
ing capacity [51], are cumbersome to use [54], and might
result in unintentional overcooling [55]. Recently, a new
cooling pad was introduced, which is stored at -2°C in a
mobile cooling box in the ambulance car [53]: in this
study, cooling was initiated at a median 12 minutes (IQR
8.5-15) after restoration of spontaneous circulation, and
an oesophageal temperature of 33°C was achieved within
median 70 minutes (IQR 55-106) after start of cooling,
with a median cooling rate of 3.3°C/hour (IQR 2.0-4.0).
Infusion of cold fluid after successful resuscitation is also
an easy to use cooling method in the out-of-hospital set-
ting [56,57]. In the first study investigating feasibility of
cold infusion during transport to the hospital [56], 13
patients were treated with 30 ml/kg of ice-cold Ringer's
acetate intravenously with an infusion rate of 100 ml/
min; oesophageal temperature decreased by 1.8°C, from
35.8°C to 34.0°C at admission; no results were given on
the temperature course after admission. In another study
[57], a total of 125 patients were randomized to receive
standard care with or without intravenous field cooling;
of the 63 patients randomized to cooling, 49 (78%)
received an infusion of 500 to 2000 mL of 4°C normal
saline before hospital arrival; these 63 patients experi-
enced a mean temperature decrease of 1.2 ± 1.0°C with a
hospital arrival temperature of 34.7°C, whereas the 62
patients not randomized to cooling experienced a mean
temperature increase of 0.1 ± 0.9°C (P < 0.0001) with a
hospital arrival temperature of 35.7°C; magnitude of tem-
perature decrease correlated with the amount of volume
infused; no adverse consequences in terms of blood pres-
sure, heart rate, arterial oxygenation, evidence for pulmo-
nary oedema on initial chest x-ray, or re-arrest were
reported; moreover, the volume load might aid to hemo-
dynamic improvement. The authors of this study [57]
reported also on outcome, there was a trend for awaken-
ing and discharged alive from hospital only in ventricular
fibrillation patients; main limitations of this study were
that not all patients received the full amount of cold fluid,
and that patients may or may not have been treated with
mild hypothermia in the receiving hospital. These limita-
tions prevent to draw any conclusion of the potential ben-
eficial effect of early cooling on neurologic outcome.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:52 http://www.sjtrem.com/content/17/1/52
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Using cold intravenous fluids might have some limita-
tions: to be effective, infusion must be fast [41], requiring
large-bore cannula access which might not be available in
all cardiac arrest cases; pulmonary oedema would con-
traindicate the application of fluids; and re-warming is
rapid within 60-90 minutes, requiring an additional cool-
ing method to maintain mild hypothermia [40,41,58].
Combination of cold intravenous fluids with cool-packs
or cooling pads in the out-of-hospital setting might over-
come these limitations and should be evaluated in further
clinical trials.
The potential benefits of starting the cooling process
already in the out-of-hospital setting are not limited to
duration of cooling during driving time from scene to
hospital. In Vienna, average driving time from scene to the
emergency department is only 10 minutes (personal com-
munication with the Medical Director of the Vienna
Ambulance System); but in the Vienna study with out-of-
hospital cooling [53], time from successful resuscitation
to arrival at the emergency department was 45 minutes.
This includes stabilisation of patient, and transport of
patient from the actual location of cardiac arrest (could be
the 5th floor of an apartment house without elevator) to
the ambulance car. At arrival at the emergency depart-
ment, cooling had been in progress for 30 minutes and
had decreased oesophageal temperature to 35.4°C; target
temperature of 33°C was reached within 91 minutes. In
the hospital, time to start cooling takes considerably
longer: in an Europe-wide multicentre registry of 465
patients treated with hypothermia after cardiac arrest,
cooling was initiated at 131 minutes after resuscitation,
with a cooling rate of 1.1°C/h [43]. In two other in-hos-
pital studies, time to start cooling was 120 minutes [46],
and 95 minutes respectively [48]. Thus, with out-of-hos-
pital cooling, delay of in-hospital cooling was prevented,
and target temperature of 33°C was not only reached con-
siderably faster as compared to in-hospital cooling, target
temperature was reached, even before cooling could be
initiated in the emergency department [53]. If early cool-
ing in the out-of-hospital setting will improve neurologic
outcome needs to be investigated in a prospective, rand-
omized, and sufficiently powered clinical trial.
Conclusion
Since 2005, the European Resuscitation Council recom-
mends in its guidelines the use of mild therapeutic hypo-
thermia (32-34°) for 12 to 24 hours in patients
successfully resuscitated from cardiac arrest. The benefit of
resuscitative hypothermia (induced after resuscitation) is
well established, while the benefit of preservative hypo-
thermia (induced during cardiac arrest) needs further
investigation before recommending it for clinical routine.
Animal data and limited human data suggest that early
and fast cooling might augment the beneficial effect of
resuscitative mild hypothermia. Out-of-hospital cooling
was shown to be feasible and safe by means of infusion
with cold saline or non-invasively with cooling pads. A
combination of these cooling methods might further
improve cooling efficacy. If out-of-hospital cooling will
improve functional outcome as compared with in-hospi-
tal cooling needs to be determined.
Despite all the knowledge about hypothermia acquired
up to day, additional studies are needed to better define
the optimal depth and duration of hypothermia, the role
of sedatives and paralytics during cooling, and the opti-
mal re-warming rate after cooling, and to improve the
techniques for inducing hypothermia. We strongly
encourage joining the international hypothermia network
http://www.hypothermianetwork.com to enable properly
powered, prospective, randomized trials to address all
these issues.
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